Macori and Cotter's Current Opinion in Biotechnology review (2018, 49:172β178) synthesizes recent progress on the microbiology of fermented dairy foods, arguing that culture-dependent and culture-independent ('omics') methods jointly reveal community complexity and functionality that earlier approaches missed. The paper is organized around product categories: yogurt (the Str. thermophilus/Lb. bulgaricus protosymbiosis, including the documented genetic evolution of ancestral bulgaricus strains toward intermediate acetaldehyde production), cheese (metagenomic surveys showing rich, geo-shaped communities usable as microbial ecology models including horizontal gene transfer), and traditional fermented milks.
These three ranges come directly from the paper's Table 1 categorization of thermophilic sour-milks, mesophilic sour-milks, and acid-alcoholic milks.
On the kefir claims, the review cites a companion Frontiers review describing >50 LAB and yeast species in some grains and health effects (anti-allergenic, anti-carcinogenic, anti-obesity) β but these are overwhelmingly from rodent models. The review's forward-looking stance on shotgun metagenomics as a safety tool was subsequently vindicated conceptually β e.g., a dedicated nunu strain-level metagenomic study identified virulence factors and safety risks β and broader metagenomics reviews confirmed amplicon biases and gene-expression/capacity distinctions as the key methodological caveats the review anticipated. Modern post-2017 work extends the review's starter-culture thesis with metabolomics: strain-specific co-cultures (L. paracasei L9 vs L. acidophilus LAC) measurably modulate yogurt acidification kinetics (L9 shortened fermentation ~0.5 h; TA 36.56 vs 25.20 Β°T at 3 h) and 21-day storage viability (>9.0 vs 6.02 log CFU/g), via distinct pathways (glycerophospholipid/pantothenate-CoA vs arginine/BCAA).
Strengths: authoritative synthesis by Teagasc/APC leaders; excellent product catalog (Table 1); timely emphasis on culture-independent sequencing; no declared conflicts of interest. Weaknesses/blind spots: (1) health-benefit claims (yogurtβdiabetes, kefirβbone density) are stated without caveats about observational confounding β yogurt-consumption associations with type 2 diabetes in elderly Spanish and US cohorts are hypothesis-generating, not causal; (2) the safety dimension is thin β the review does not engage with predictive microbiology showing pasteurization can paradoxically favor L. monocytogenes growth (2.02 log-unit increase in smeared cheese) versus raw-milk backgrounds; (3) reference fidelity issues in the compiled bibliography (e.g., Ling et al. 2015 Nature teixobactin paper miscategorized under starter-culture methods) suggest hurried editing; (4) the review's generality claim that "the continued application promises to maximize health-promoting properties" remains speculative β no randomized human trials are cited for any product. Confidence: the microbiological/ecological content is well-supported by primary studies; the health claims remain the weakest evidentiary pillar.
If well-powered human RCTs showed fermented dairy metabolite signatures (per the L9/LAC work) failing to replicate animal-model benefits, or if systematic outbreak surveillance showed cheese hazards dominated by pathogens the review omitted, the review's optimism and scope would need revision. Conversely, its core microbiological claims (community geography-dependence, protosymbiosis genetics, omics utility) are robust and were confirmed by subsequent high-throughput work.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.